Strategy

For Bioalliance Pharma delivery is the innovation

Thursday 10 September 2009

Interviewee/Contributer: Dominique Constantini

Organisation: BioAlliance

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Novo Nordisk Biotech Fund

Thursday 10 September 2009

Interviewee/Contributer: Johannes Jensen

Organisation: Novo Nordisk Biotech Fund

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How consolidation may affect biotech innovation

Monday 15 June 2009

Interviewee/Contributer: Gareth Williams

Organisation: Marks & Clerk LLP

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How Galapagos built a business from discovery

Tuesday 10 February 2009

Interviewee/Contributer: Onno van de Stolpe

Organisation: Galapagos NV

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How Innate Pharma turned a threat into an opportunity

Monday 10 November 2008

Interviewee/Contributer: Herve Brailly

Organisation: Innate Pharma SA

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How Ablynx uses the llama to create antibodies

Wednesday 10 September 2008

Interviewee/Contributer: Edwin Moses

Organisation: Ablynx NV

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Medigene moves further into oncology

Tuesday 10 June 2008

Interviewee/Contributer: Peter Heinrich

Organisation: Medigene AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Silence Therapeutics:Silencing the gene that codes the protein

Thursday 10 April 2008

Interviewee/Contributer: Jeffery Vick

Organisation: Silence Therapeutics Plc

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How Addex Pharmaceuticals secured two multimilion dollar deals with Merck

Monday 10 March 2008

Interviewee/Contributer: Vincent Mutel

Organisation: Addex Pharmaceuticals

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Four smart chemists meet two billionaire investors

Sunday 10 February 2008

Interviewee/Contributer: Ulrich Dauer

Organisation: 4SC AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content